James Abbruzzese, MD

Publications

Dong, X, Li, Y, Tang, H, Chang, P, Hess, KR, Abbruzzese, JL, and Li, D. "Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer." Cancer epidemiology 36, no. 2 (April 2012): 206-211.

PMID
21852217
Full Text

Kaseb, AO, Morris, JS, Hassan, MM, and Abbruzzese, JL. "Reply to A. Goyal et al." Journal of Clinical Oncology 30, no. 9 (March 20, 2012): 1019-1020.

Full Text

Chatterjee, D, Katz, MH, Rashid, A, Wang, H, Iuga, AC, Varadhachary, GR, Wolff, RA, Lee, JE, Pisters, PW, Crane, CH, Gomez, HF, Abbruzzese, JL, Fleming, JB, and Wang, H. "Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma." The American journal of surgical pathology 36, no. 3 (March 2012): 409-417.

PMID
22301497
Full Text

Dakik, HK, Moskovic, DJ, Carlson, PJ, Tamm, EP, Qiao, W, Wolff, RA, Abbruzzese, JL, and Fogelman, DR. "The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis." Cancer chemotherapy and pharmacology 69, no. 2 (February 2012): 425-430.

PMID
21850466
Full Text

Hammond-Thelin, LA, Thomas, MB, Iwasaki, M, Abbruzzese, JL, Lassere, Y, Meyers, CA, Hoff, P, de Bono, J, Norris, J, Matsushita, H, Mita, A, and Rowinsky, EK. "Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies." Investigational new drugs 30, no. 1 (February 2012): 316-326.

PMID
20839029
Full Text

Kaseb, AO, Garrett-Mayer, E, Morris, JS, Xiao, L, Lin, E, Onicescu, G, Hassan, MM, Hassabo, HM, Iwasaki, M, Deaton, FL, Abbruzzese, JL, and Thomas, MB. "Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial." Oncology 82, no. 2 (January 2012): 67-74.

PMID
22327795
Full Text

Zhao, Q, Rashid, A, Gong, Y, Katz, MH, Lee, JE, Wolf, R, Balachandran, A, Varadhachary, GR, Pisters, PW, Wang, H, Gomez, HF, Abbruzzese, JL, Fleming, JB, and Wang, H. "Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis." Annals of diagnostic pathology 16, no. 1 (January 2012): 29-37.

PMID
22050964
Full Text

Katz, MHG, Wang, H, Balachandran, A, Bhosale, P, Crane, CH, Wang, X, Pisters, PWT, Lee, JE, Vauthey, J-N, Abdalla, EK, Wolff, R, Abbruzzese, J, Varadhachary, G, Chopin-Laly, X, Charnsangavej, C, and Fleming, JB. "Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer." Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 16, no. 1 (January 2012): 68-78.

PMID
22065318
Full Text

Estrella, JS, Rashid, A, Fleming, JB, Katz, MH, Lee, JE, Wolf, RA, Varadhachary, GR, Pisters, PWT, Abdalla, EK, Vauthey, J-N, Wang, H, Gomez, HF, Evans, DB, Abbruzzese, JL, and Wang, H. "Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation." Cancer 118, no. 1 (January 2012): 268-277.

PMID
21735446
Full Text

Fogelman, D, Jafari, M, Varadhachary, GR, Xiong, H, Bullock, S, Ozer, H, Lin, E, Morris, J, Cunningham, P, Bennett, B, Abbruzzese, JL, and Wolff, RA. "Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial." Cancer chemotherapy and pharmacology 68, no. 6 (December 2011): 1431-1438.

PMID
21479635
Full Text

Pages